BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 9817026)

  • 1. Protein-tyrosine phosphatases: structure, mechanism, and inhibitor discovery.
    Burke TR; Zhang ZY
    Biopolymers; 1998; 47(3):225-41. PubMed ID: 9817026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic approaches to studying protein tyrosine phosphatases.
    Liang F; Kumar S; Zhang ZY
    Mol Biosyst; 2007 May; 3(5):308-16. PubMed ID: 17460790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Src homology-2 domains: structure, mechanisms, and drug discovery.
    Sawyer TK
    Biopolymers; 1998; 47(3):243-61. PubMed ID: 9817027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphoryltyrosyl mimetics in the design of peptide-based signal transduction inhibitors.
    Burke TR; Yao ZJ; Liu DG; Voigt J; Gao Y
    Biopolymers; 2001; 60(1):32-44. PubMed ID: 11376431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical and mechanistic approaches to the study of protein tyrosine phosphatases.
    Zhang ZY
    Acc Chem Res; 2003 Jun; 36(6):385-92. PubMed ID: 12809524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MAPK-specific tyrosine phosphatases: new targets for drug discovery?
    Barr AJ; Knapp S
    Trends Pharmacol Sci; 2006 Oct; 27(10):525-30. PubMed ID: 16919785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allele-specific inhibitors of protein tyrosine phosphatases.
    Hoffman HE; Blair ER; Johndrow JE; Bishop AC
    J Am Chem Soc; 2005 Mar; 127(9):2824-5. PubMed ID: 15740097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular inhibition of protein tyrosine phosphatase 1B by uncharged thioxothiazolidinone derivatives.
    Stuible M; Zhao L; Aubry I; Schmidt-Arras D; Böhmer FD; Li CJ; Tremblay ML
    Chembiochem; 2007 Jan; 8(2):179-86. PubMed ID: 17191286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation.
    Denu JM; Tanner KG
    Biochemistry; 1998 Apr; 37(16):5633-42. PubMed ID: 9548949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of protein tyrosine phosphatases: next-generation drugs?
    Bialy L; Waldmann H
    Angew Chem Int Ed Engl; 2005 Jun; 44(25):3814-39. PubMed ID: 15900534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yeast substrate-trapping system for isolating substrates of protein tyrosine phosphatases: Isolation of substrates for protein tyrosine phosphatase receptor type z.
    Fukada M; Kawachi H; Fujikawa A; Noda M
    Methods; 2005 Jan; 35(1):54-63. PubMed ID: 15588986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural compounds as a source of protein tyrosine phosphatase inhibitors: application to the rational design of small-molecule derivatives.
    Ferreira CV; Justo GZ; Souza AC; Queiroz KC; Zambuzzi WF; Aoyama H; Peppelenbosch MP
    Biochimie; 2006 Dec; 88(12):1859-73. PubMed ID: 17010496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligands and signaling through receptor-type tyrosine phosphatases.
    Bixby JL
    IUBMB Life; 2001 Mar; 51(3):157-63. PubMed ID: 11547917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyrosine phosphoproteomics and identification of substrates of protein tyrosine phosphatase dPTP61F in Drosophila S2 cells by mass spectrometry-based substrate trapping strategy.
    Chang YC; Lin SY; Liang SY; Pan KT; Chou CC; Chen CH; Liao CL; Khoo KH; Meng TC
    J Proteome Res; 2008 Mar; 7(3):1055-66. PubMed ID: 18281928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signal transduction drug discovery: targets, mechanisms and structure-based design.
    Dalgarno DC; Metcalf CA; Shakespeare WC; Sawyer TK
    Curr Opin Drug Discov Devel; 2000 Sep; 3(5):549-64. PubMed ID: 19649883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. K vitamins, PTP antagonism, and cell growth arrest.
    Carr BI; Wang Z; Kar S
    J Cell Physiol; 2002 Dec; 193(3):263-74. PubMed ID: 12384979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein tyrosine phosphatase inhibitors: a patent review (2002 - 2011).
    Sobhia ME; Paul S; Shinde R; Potluri M; Gundam V; Kaur A; Haokip T
    Expert Opin Ther Pat; 2012 Feb; 22(2):125-53. PubMed ID: 22332719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrosine phosphatases such as SHP-2 act in a balance with Src-family kinases in stabilization of postsynaptic clusters of acetylcholine receptors.
    Camilleri AA; Willmann R; Sadasivam G; Lin S; Rüegg MA; Gesemann M; Fuhrer C
    BMC Neurosci; 2007 Jul; 8():46. PubMed ID: 17605785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global analysis of protein tyrosine phosphatase activity with ultra-sensitive fluorescent probes.
    Kumar S; Zhou B; Liang F; Yang H; Wang WQ; Zhang ZY
    J Proteome Res; 2006 Aug; 5(8):1898-905. PubMed ID: 16889411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosine phosphatases as regulators of skeletal development and metabolism.
    Schiller KR; Mauro LJ
    J Cell Biochem; 2005 Oct; 96(2):262-77. PubMed ID: 16052478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.